Schedule 13D ownership disclosure
ALX Oncology Holdings, Inc.
Security class unavailable · CUSIP: 00166B105
Event date: 2023-12-15
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,366,530
- Percent of class
- 2.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-024164
- Form type
- SC 13D
- Filer
- ALX ONCOLOGY HOLDINGS INC
- CIK
- CIK 1810182
- Filed
- Feb 14, 2024
- Reporting period
- Dec 15, 2023
- Description
- Schedule 13D beneficial ownership